Back to Results
First PageMeta Content
Health / Autoimmune diseases / Arthritis / Monoclonal antibodies / Ustekinumab / Etanercept / National Psoriasis Foundation / Secukinumab / Biologic / Psoriasis / Immunosuppressants / Medicine


Novartis Pharmaceuticals Canada Inc. 385 Bouchard Blvd. Dorval, Quebec Canada H9S 1A9 www.novartis.ca
Add to Reading List

Document Date: 2015-05-13 10:22:14

Open Document

File Size: 418,31 KB

Share Result on Facebook

City

San Francisco / Montréal / Basel / Usher / /

Company

Amgen Inc. / Fleischer AB / Nestle / Novartis Group / Novartis Pharmaceuticals Canada Inc. / Janssen Biotech Inc. / External Communications Novartis Pharmaceuticals Canada Inc. / /

Continent

Asia / North America / Europe / /

Country

Switzerland / United States / Canada / Australia / /

Currency

USD / /

/

Event

FDA Phase / Earnings Announcement / /

Facility

Laval University / McMaster University / /

IndustryTerm

healthcare / psoriasis care / pharmaceuticals / treatment of psoriasis / /

MarketIndex

Psoriasis Area Severity / /

MedicalCondition

arthritis / physical and emotional impact moderate-to-severe plaque psoriasis / psoriasis / psoriatic arthritis / moderate-to-severe psoriasis / disease / chronic / itching / skin disease / autoimmune disease / diseases / moderate-to-severe plaque psoriasis / inflammatory / /

Organization

Laval University / McMaster University / American Academy of Dermatology / /

Person

Elizabeth Tanguay / Ron Vender / Brit J Dermatol / Yves Poulin / Gregory V / /

/

Position

Manager / Vice President / messenger / leader / assistant professor / Major / Professor of Medicine / /

Product

Enbrel / Cosentyx™ / Stelara / Cosentyx / A2302E1 / Stelara® / /

ProvinceOrState

Quebec / Pennsylvania / California / /

URL

http /

SocialTag